Home › Meningioma › Georgia
Meningioma clinical trials in Georgia
5 studies for Meningioma are looking for participants at sites in Georgia.
Cities in Georgia
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Piedmont Healthcare, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Piedmont Healthcare, Atlanta
- Winship Cancer Institute of Emory University, Atlanta
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
- Emory University Hospital/Winship Cancer Institute, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT04278118Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 10, 2026 · NCT06132685From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.